| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/17/2002 | US6451606 Receptacle unit for solutions, in particular solutions for calibration of sensors for measuring physiologically relevant parameters |
| 09/17/2002 | US6451598 Assaying whether a candidate agent inhibits fusion of an enveloped virion and its target cell; screening for anti-hiv agents |
| 09/17/2002 | US6451591 Device and method for the determination of protein domain boundaries |
| 09/17/2002 | US6451582 Staphylococcus strains comprising an inducible gene encoding an RNA polymerase specificity factor |
| 09/17/2002 | US6451578 Hepatitis, amino acid sequences and nucleic acids |
| 09/17/2002 | US6451577 Human uridine disphosphate galactose-4-epimerase |
| 09/17/2002 | US6451575 The invention is directed to the family of aggrecan degrading metallo proteases (admps) that exhibit the ability to cleave the aggrecan core protein between amino acid residues glu.sup.373 -ala.sup.374. the invention encompasses the |
| 09/17/2002 | US6451569 Synthetic molecules that specifically react with target sequences |
| 09/17/2002 | US6451561 Growth hormone variants |
| 09/17/2002 | US6451555 Nucleic acid probes for detecting mutations and the methylation patterns of nucleic acids. the methods of the present invention are particularly useful for detecting and isolating genomic dna fragments which are near coding and |
| 09/17/2002 | US6451554 Purified nucleic acid sequence encoding a sodium channel protein wherein said nucleic acid sequence comprises the coding portion of the nucleic acid sequence and producing a mammalian sensory neuron sodium channel protein, wherein the |
| 09/17/2002 | US6451551 Contacting the embedded tissue specimen with a releasing composition under conditions sufficient to release a sufficient portion of the embedding medium associated with the histochemically reactive tissue specimen to permit analysis |
| 09/17/2002 | US6451550 Haptoglobin assay |
| 09/17/2002 | US6451547 Process for differential diagnosis of Alzheimer's dementia and device therefor |
| 09/17/2002 | US6451546 Plant glurs of the invention may function as signal transducers involved in the regulation of plant growth. the invention also relates to the identification of compounds that modulate the activity of the plant glur and herbicides |
| 09/17/2002 | US6451544 Identification of agents that protect against inflammatory injury to neurons |
| 09/17/2002 | US6451543 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 09/17/2002 | US6451542 Level (by weight/volume, w/v) of haptoglobin (hp) to the level (by weight/volume, w/v) of apolipoprotein a1 (apo a1) in a patient. in addition, the invention also provides a method for diagnosing patient and identification of phenotypes |
| 09/17/2002 | US6451541 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPsc |
| 09/17/2002 | US6451534 Kvlqt1 and kcne1 which are genes associated with long qt syndrome. additional sequence data for the two genes are also disclosed. mutations in kvlqt1 which result in long qt syndrome. the intron/exon junction sequence data allow for the |
| 09/17/2002 | US6451531 Dioxetane labeled probes and detection assays employing the same |
| 09/17/2002 | US6451523 Variant form of the receptor for the obese gene product. the invention relates to methods of detecting this receptor variant in cells and tissues of obese individuals. |
| 09/17/2002 | US6451522 Combining agent to be tested, antibody or antigen-binding fragment which binds to amino terminal domain of mammalian cc-chemokine receptor 2, mammalian cc-chemokine receptor 2 or ligand-binding variant, measuring binding |
| 09/17/2002 | US6451368 Administering milk from lactating cow producing milk with casein variant having proline at position 67 instead of histidine |
| 09/17/2002 | US6451353 Ultrasonically dissolvin; solvent extraction from water with chloroform; degreasing; blending with acetic ether; drying with calcium chloride; filtration, suspension; injection into cartridge using epicatechin as standard |
| 09/17/2002 | US6451324 Ryegrass pollen allergen |
| 09/17/2002 | US6451315 Compounds and methods for the diagnosis and treatment of B. microti infection |
| 09/17/2002 | US6451313 Heterotetramer; expression vectors encoding heavy and light chains; viricides |
| 09/17/2002 | US6451311 An antibody which binds procalcitonin but not free calcitonin, free katacalcin and free n-procalcitonin; used as an in vitro or in vivo diagnostic agent |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | US6451260 Method for producing microporous elements, the microporous elements thus produced and uses thereof |
| 09/17/2002 | US6451225 Mixtures of chelate compounds, amines and electrolytes used for chemical and quantitative analysis; detection of electromagnetic radiations emitted; accuracy |
| 09/17/2002 | US6451212 Monitoring variations in electrical potentials |
| 09/17/2002 | US6451210 Method and system to remotely monitor a carbon adsorption process |
| 09/17/2002 | US6451207 Magnetic cell separation device |
| 09/17/2002 | US6451196 Biosensors having ionophores in lipid membrane coatings on metal electrodes; applying direct currents voltages superimposed onto alternating current impedance signals to influence conductivity; sensitivity |
| 09/17/2002 | US6451191 Film based addressable programmable electronic matrix articles and methods of manufacturing and using the same |
| 09/17/2002 | US6450008 Food applications of artificial olfactometry |
| 09/17/2002 | US6450007 Robust single-chip hydrogen sensor |
| 09/17/2002 | CA2278878C Very large scale immobilized peptide synthesis |
| 09/17/2002 | CA2274453C Method and apparatus for analyzing asphalt content |
| 09/17/2002 | CA2254792C Process and devices for characterising ground water measurement points by distinguishing ground water from subterranean water accumulation |
| 09/17/2002 | CA2243459C Human antibodies that bind human tnf.alpha. |
| 09/17/2002 | CA2242693C Additive formulation and method of use thereof |
| 09/17/2002 | CA2204151C Cdna encoding a bmp type ii receptor |
| 09/17/2002 | CA2196254C Method and reagent kit for determining paper degradation in transformers |
| 09/17/2002 | CA2145405C Nucleotides labelled with an infrared dye and their use in nucleic acid detection |
| 09/17/2002 | CA2122036C Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form |
| 09/17/2002 | CA2111853C Substantially pure receptor like tgf-.beta.1 binding molecules and uses thereof |
| 09/17/2002 | CA2087966C Reusable test unit for simulating electrochemical sensor signals for quality assurance of portable blood analyzer instruments |
| 09/17/2002 | CA2067919C Heterobifunctional antibodies possessing dual catalytic and specific antigen binding properties and methods using them |
| 09/17/2002 | CA2042974C Use of a 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for the manufacture of a medicament for the treatment of cerebral and neuronal diseases |
| 09/16/2002 | CA2373468A1 Reg-like protein |
| 09/13/2002 | CA2374027A1 Cloning, expression, sequencing, and functional enhancement of monoclonal scfv antibody against venezuelan equine encephalitis virus(vee) |
| 09/12/2002 | WO2002071336A1 Method for localizing and identifying epitopes |
| 09/12/2002 | WO2002071075A1 Improvements in or relating to assessment of fertility |
| 09/12/2002 | WO2002071074A2 Method for analyzing proteins |
| 09/12/2002 | WO2002071073A2 Screening system based on expression of abcg2 half transporter protein |
| 09/12/2002 | WO2002071072A2 Method and device for processing proteins in gels |
| 09/12/2002 | WO2002071071A2 Assays involving reporter systems on carriers |
| 09/12/2002 | WO2002071070A2 β-ADRENOCEPTOR GENETIC POLYMORPHISMS AND OBESITY |
| 09/12/2002 | WO2002071069A1 Method of analyzing specimen with the use of specific bond |
| 09/12/2002 | WO2002071068A1 Method for detecting macromolecular biopolymers by using at least one immobilizing unit provided with a marked scavenger molecule |
| 09/12/2002 | WO2002071067A1 Assay system for simultaneous detection and measurement of multiple modified cellular proteins |
| 09/12/2002 | WO2002071066A1 Protein profiling platform |
| 09/12/2002 | WO2002071065A1 Immunological detection of prostate diseases and prostasome-related conditions |
| 09/12/2002 | WO2002071064A1 Method of examining steroid-responsiveness |
| 09/12/2002 | WO2002071062A2 Diagnosis and treatment of inflammation and hyperactive immune conditions |
| 09/12/2002 | WO2002071061A2 Quantitative detection of the conformation changes of p-glycoprotein |
| 09/12/2002 | WO2002071060A2 Use of metabolic phenotyping in individualized treatment with amonafide |
| 09/12/2002 | WO2002071059A1 A system and method for managing gene expression data |
| 09/12/2002 | WO2002071055A1 Automated immunohistochemical and in situ hybridzation assay formulations |
| 09/12/2002 | WO2002071051A2 Acoustic sample introduction for analysis and/or processing |
| 09/12/2002 | WO2002071050A1 Method and device for monitoring and controlling a process |
| 09/12/2002 | WO2002071044A1 Distinguishing test types through spectral analysis |
| 09/12/2002 | WO2002071040A2 Use of infrared spectroscopy in genotypic analysis |
| 09/12/2002 | WO2002071039A1 A method for measuring hemoglobin concentration (hgb) in the blood in a circuit of a dialysis machine, measuring device and circuit for the application of the method |
| 09/12/2002 | WO2002071037A2 Apparatus and method for processing and testing a biological specimen |
| 09/12/2002 | WO2002071033A2 Dissolution test apparatus |
| 09/12/2002 | WO2002070752A1 Assay for hepatitis c virus helicase (ns3) rna binding |
| 09/12/2002 | WO2002070751A1 Pcr method |
| 09/12/2002 | WO2002070748A2 Response of dendritic cells to a diverse set of pathogens |
| 09/12/2002 | WO2002070747A1 Method of molecular diagnosis of chronic myelogenous leukemia |
| 09/12/2002 | WO2002070746A2 Methods for global profiling gene regulatory element activity |
| 09/12/2002 | WO2002070744A2 Adenoviral library assay for e2f regulatory genes and methods and compositions for screening compounds |
| 09/12/2002 | WO2002070743A2 Identification and use of inhibitors of hair growth |
| 09/12/2002 | WO2002070742A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 09/12/2002 | WO2002070741A2 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 09/12/2002 | WO2002070739A2 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv |
| 09/12/2002 | WO2002070737A2 Compositions and methods relating to osteoarthritis |
| 09/12/2002 | WO2002070736A2 Method for the detection of nucleic acid molecules |
| 09/12/2002 | WO2002070734A1 Method for determining concentration of an analyte in a test strip |
| 09/12/2002 | WO2002070733A1 Method for detecting macromolecular biopolymers by using at least one nanoparticle provided with a scavenger molecule |
| 09/12/2002 | WO2002070732A2 Method for assaying non-spermine/spermidine activity of spermidine/spermine n1acetyltransferase (ssat) |
| 09/12/2002 | WO2002070731A2 Methods and primers for evaluating hiv-1 mutations |
| 09/12/2002 | WO2002070730A2 Models and methods for determining systemic properties of regulated reaction networks |
| 09/12/2002 | WO2002070729A2 Improved skin substitutes and uses thereof |
| 09/12/2002 | WO2002070716A1 Allergen ole e 9 from olea europaea, recombinant dna coding for said allergen, the production and use thereof |
| 09/12/2002 | WO2002070708A2 Glutamate receptor modulatory proteins and nucleic acids encoding them |
| 09/12/2002 | WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |